Details for New Drug Application (NDA): 211622
✉ Email this page to a colleague
The generic ingredient in SOLIFENACIN SUCCINATE is solifenacin succinate. There are thirty drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the solifenacin succinate profile page.
Summary for 211622
Tradename: | SOLIFENACIN SUCCINATE |
Applicant: | Lannett Co Inc |
Ingredient: | solifenacin succinate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 211622
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Jun 6, 2023 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Jun 6, 2023 | TE: | RLD: | No |
Complete Access Available with Subscription